Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
COVID-19 vaccines used in Brazil are from ... that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there ...
Additionally, vaccines with similar technology show that antibodies can migrate: For instance, with Moderna’s Covid-19 vaccine, antibodies are shown to move to sites of infection in the nose.
Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...
Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...
Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.
Six deaths reported this past week in McLeod County were attributed to COVID-19, according to data from the Minnesota Department of Health. It was the deadliest week of the pandemic since last ...
following earlier approved vaccines from Pfizer (PFE) and GSK (GSK). A health worker prepares a Moderna COVID-19 vaccine at a vaccination center. (AP Photo/K.M. Chaudary) · ASSOCIATED PRESS ...
"This agreement presents an opportunity for Moderna to support and strengthen national COVID-19 vaccination campaigns across participating countries," said Chantal Friebertshäuser, Senior Vice ...
Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to ...